Literature DB >> 3969206

Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam.

R M Garruto, R Yanagihara, D C Gajdusek.   

Abstract

The high incidence rates of amyotrophic lateral sclerosis (ALS) and parkinsonism-dementia (PD) occurring among the Chamorros of Guam have declined to rates only slightly higher than those observed in the continental United States. This decline has occurred principally among males, especially those born after 1920 and living in areas where calcium and magnesium levels are low in soil and water. The male-to-female ratio among affected patients now approaches unity, compared with ratios of 2 to 1 for ALS and 3 to 1 for PD three decades ago. These changes are consistent with the hypothesis that the previously high incidence resulted from defects in mineral metabolism and secondary hyperparathyroidism, provoked by nutritional deficiencies of calcium and magnesium, with resultant deposition of calcium and aluminum in neurons.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3969206     DOI: 10.1212/wnl.35.2.193

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  37 in total

1.  A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents.

Authors:  L G Gunnarsson; L Bodin; B Söderfeldt; O Axelson
Journal:  Br J Ind Med       Date:  1992-11

2.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

3.  Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy.

Authors:  Wan Yang; Randall L Woltjer; Izabela Sokal; Catherine Pan; Yan Wang; Mary Brodey; Elaine R Peskind; James B Leverenz; Jing Zhang; Daniel P Perl; Douglas R Galasko; Thomas J Montine
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

4.  Aluminum and the pathogenesis of dialysis dementia.

Authors:  A I Arieff
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

5.  Cerebrovascular inflammation is associated with tau pathology in Guam parkinsonism dementia.

Authors:  Petra Majerova; Ralph M Garruto; Andrej Kovac
Journal:  J Neural Transm (Vienna)       Date:  2018-04-26       Impact factor: 3.575

6.  Models of environmentally induced neurological disease: epidemiology and etiology of amyotrophic lateral sclerosis and parkinsonism-dementia in the Western Pacific.

Authors:  R M Garruto; R Yanagihara; D C Gajdusek
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

7.  Parkinson-dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissue.

Authors:  Laura R Snyder; Reyniel Cruz-Aguado; Martin Sadilek; Douglas Galasko; Christopher A Shaw; Thomas J Montine
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-28       Impact factor: 4.219

8.  Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates.

Authors:  Weiva Sieh; Yoonha Choi; Nicola H Chapman; Ulla-Katrina Craig; Ellen J Steinbart; Joseph H Rothstein; Kiyomitsu Oyanagi; Ralph M Garruto; Thomas D Bird; Douglas R Galasko; Gerard D Schellenberg; Ellen M Wijsman
Journal:  Hum Mol Genet       Date:  2009-06-30       Impact factor: 6.150

Review 9.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

10.  Was a neurovirulent influenza virus the cause of amyotrophic lateral sclerosis and parkinsonism-dementia on Guam?

Authors:  C P Maurizi
Journal:  Med Hypotheses       Date:  1987-07       Impact factor: 1.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.